Back
Avalo Therapeutics, Inc. Stock Predictions
Get Paid In ANY Crypto Market
Learn the crash-proof system. Watch the free training.
Sell
43
AVTX
Avalo Therapeutics, Inc.
Last Price:
$16.04
Seasonality Move:
0.84%
7 Day Trial
ALL ACCESS PASS
$
7
BlackRock's $91B Secret
Learn how to access Native Markets before Coinbase. Watch the free training.Avalo Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Avalo Therapeutics, Inc. has on average historically fallen by 6.8% based on the past 10 years of stock performance.
-
Avalo Therapeutics, Inc. has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Avalo Therapeutics, Inc. Stock Undervalued?The current Avalo Therapeutics, Inc. [AVTX] share price is $18.16. The Score for AVTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
AVTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Avalo Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Avalo Therapeutics, Inc. has on average historically fallen by 6.8% based on the past 10 years of stock performance.
Avalo Therapeutics, Inc. Stock Rating
Sell
43
Avalo Therapeutics, Inc. (AVTX)
is a Sell
Is Avalo Therapeutics, Inc. overpriced?
-
Avalo Therapeutics, Inc. has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Avalo Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
avalotx.com
52-Week Data
52-Week High:
20.72
52-Week Low:
3.39
Prediction Charts
Market Cap:
308.6M
Price in USD:
18.16
Volume:
190.9K
Beta:
1.29
Technical Analysis
SMA50:
17.61
SMA100:
14.44
SMA200:
9.95
52-Wk Change:
101.9%
Stock Predictions
-
Is Avalo Therapeutics, Inc. stock public?Yes, Avalo Therapeutics, Inc. is a publicly traded company.
-
What is the Avalo Therapeutics, Inc. stock quote today?The Avalo Therapeutics, Inc. stock price is 18.16 USD today.
-
How to buy Avalo Therapeutics, Inc. stock online?You can buy Avalo Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-10 | 19.48 | 19.95 | 20.25 | 19.25 |
| Dec-11 | 19.95 | 19.51 | 20.72 | 19.51 |
| Dec-12 | 19.00 | 18.60 | 19.39 | 18.03 |
| Dec-15 | 18.61 | 17.70 | 20.28 | 17.62 |
| Dec-16 | 17.54 | 18.82 | 19.70 | 17.18 |
| Dec-17 | 19.00 | 19.25 | 20.20 | 18.90 |
| Dec-18 | 20.00 | 18.91 | 20.12 | 18.80 |
| Dec-19 | 18.98 | 18.60 | 19.60 | 18.58 |
| Dec-22 | 18.62 | 19.17 | 19.97 | 18.59 |
| Dec-24 | 18.57 | 18.91 | 19.18 | 18.21 |
| Dec-26 | 18.90 | 18.37 | 19.00 | 18.20 |
| Dec-29 | 18.27 | 18.56 | 18.62 | 18.10 |
| Dec-30 | 18.49 | 17.81 | 18.50 | 17.60 |
| Dec-31 | 17.70 | 18.16 | 18.54 | 17.49 |
Avalo Therapeutics, Inc. Earnings
Avalo Therapeutics, Inc. Earnings Report: Per Share Avalo Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Avalo Therapeutics, Inc. Forecast Revenue Growth
Avalo Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Avalo Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.12 per share, and an increase next year of $1.14 per share.
* Avalo Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.